Emily F. Calderwood
Takeda (United States)(US)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Melanoma and MAPK Pathways, Coordination Chemistry and Organometallics, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods
Most-Cited Works
- → Substrate-Based Design of the First Class of Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Inhibitors(2002)187 cited
- → Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R)(2004)33 cited
- → Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors(2011)33 cited
- → Discovery and optimization of pyrazolopyrimidine sulfamates as ATG7 inhibitors(2020)30 cited
- → Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG(2016)10 cited
- → Selective Tolyl Carbon Alkylation Mediated by Imidazoline‐Directed Lithiation(2004)2 cited
- → Selective Tolyl Carbon Alkylation Mediated by Imidazoline‐Directed Lithiation.(2005)